Upcoming Key Projects And Advanced Solvents Entry Will Strengthen Future Prospects

Shared on01 May 25
Fair value Decreased 0.047%

Shared on23 Apr 25
Fair value Decreased 0.017%

Shared on17 Apr 25
Fair value Decreased 0.33%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.86%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.67%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 0.49%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.16%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 1.24%

AnalystConsensusTarget has decreased revenue growth from 16.6% to 9.3% and increased discount rate from 13.2% to 14.6%.